Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis.
[Clinical and demographic characteristics of patients with multiple sclerosis].
The influence of coping styles on long-term employment in multiple sclerosis: A prospective study.
Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Diseases More Effectively.
Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.
Pure alexia in a patient with multiple sclerosis.
Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cells.
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.
Whole Exome Sequencing Identifies the Genetic Basis of Late-Onset Leigh Syndrome in a Patient with MRI but Little Biochemical Evidence of a Mitochondrial Disorder.
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.
Urban traffic-derived nanoparticulate matter reduces neurite outgrowth via TNFα in vitro.
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients.
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.
Electroconvulsive Therapy in Multiple Sclerosis.
A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?
The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune Encephalomyelitis.
Decrease in rate of multiple sclerosis-related hospitalizations in Portugal.
Adipose-Derived Stem Cells Enhance Axonal Regeneration through Cross-Facial Nerve Grafting in a Rat Model of Facial Paralysis.
[Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis].
Journal Club: Effect of comorbidity on mortality in multiple sclerosis.
Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life.
EVASEP: A Noninterventional Study Describing the Perception of Neurologists, Patients, and Caregivers on Caregivers' Role in the Support of Patients Suffering from Multiple Sclerosis Treated with Subcutaneous Interferon Beta 1a.
Association of CD40 Gene Polymorphisms with Susceptibility to Neuromyelitis Optica Spectrum Disorders.
Pages
« first
‹ previous
…
797
798
799
800
801
802
803
804
805
…
next ›
last »